When looking at the pharmaceutical market, successful drugs for the treatment of obesity have typically demonstrated effectiveness in not just weight loss, but also the improvement of obesity-related conditions, particularly T2D
Khi hiu phn khoa hc, iu bn cn l cch dng thc t cho an ton
Prog Neuropsychopharmacol Biol 19 : 117133 Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly J, Fletcher A
The study of food addiction using animal models of binge eating
Different pharmacological trails approved DPP4 inhibitors (Sitagliptin, Saxagliptin and Alogliptin) can be used in patients with CKD or end stage renal disease